Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD
Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD
Active, not recruiting · NCT06707753 · Registry updated 2025-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD | Wet Age-related Macular Degeneration (wAMD) | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-19 | NCT06707753 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Anlong Biopharmaceutical Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences & Peking Union Hospital | Beijing | China | 2 |